Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-δ

Biochemical and Biophysical Research Communications

Volumn 354, Issue 2, 2007, Pages 427-433

  Yan, Zhen Cheng ^a   Liu, Dao Yan ^a   Zhang, Li Li ^a   Shen, Chen Yi ^a   Ma, Qun Li ^a   Cao, Ting Bing ^a   Wang, Li Juan ^a   Nie, Hai ^a   Zidek, Walter ^b   Tepel, Martin ^b   Zhu, Zhi Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cannabinoid receptor type 1; Exercise; Obesity; Peroxisome proliferator activated receptor ; Visceral adipose tissue

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; RIMONABANT; RNA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDURANCE; EXERCISE; GENE SILENCING; INTRAABDOMINAL FAT; LABORATORY TEST; LIPID DIET; LIPOHYPERTROPHY; MALE; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE;

3T3 CELLS; ADIPOSE TISSUE; ANIMALS; DISEASE MODELS, ANIMAL; MALE; METABOLIC SYNDROME X; MICE; OBESITY; PHYSICAL CONDITIONING, ANIMAL; PPAR DELTA; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

ADENOVIRIDAE; RATTUS; RATTUS NORVEGICUS;

EID: 33846569044     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.213     Document Type: Article

References (22)

1. Matsuzawa Y. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 3 (2006) 35-42
2. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21 (2000) 697-738
3. DiMarzo V., and Matias I. Endocannabinoid control of food intake and energy balance. Nat. Neurosci. 8 (2005) 585-589
4. Cota D., Marsicano G., Tschöp M., Grübler Y., Flachskamm C., Schubert M., Auer D., Yassouridis A., Thöne-Reineke C., Ortmann S., Tomassoni F., Cervino C., Nisoli E., Linthorst A.C.E., Pasquali R., Lutz B., Stalla G.K., and Pagotto U. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 112 (2003) 423-431
5. Jbilo O., Ravinet-Trillou C., Arnone M., Buisson I., Bribes E., Peleraux A., Penarier G., Soubrie P., Le Fur G., Galiegue S., and Casellas P. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J. 19 (2005) 1567-1569
6. Ravinet-Trillou C., Delgorge C., Menet C., Arnone M., and Soubrie P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. 28 (2004) 640-648
7. Lee C.H., Olson P., and Evans R.M. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144 (2003) 2201-2207
8. Marx N., Duez H., Fruchart J.C., and Staels B. Peroxisime proliferator-activated receptors and atherogenesis. Regulators of gene expression in vascular cells. Circ. Res. 94 (2004) 1168-1178
9. Wang Y.X., Lee C.H., Tiep S., Yu R.T., Ham J., Kang H., and Evans R.M. Peroxisome-proliferator-activated receptor-δ activates fat metabolism to prevent obesity. Cell 113 (2003) 159-170
10. Gregg E.W., Cauley J.A., Stone K., Thompson T.J., Bauer D.C., Cummings S.R., and Ensrud K.E. Study of osteoporotic fractures research group, relationship of changes in physical activity and mortality among older women. JAMA 289 (2003) 2379-2386
11. Slentz C.A., Duscha B.D., Johnson J.L., Ketchum K., Aiken L.B., Samsa G.P., Houmard J.A., Bales C.W., and Kraus W.E. Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE-a randomized controlled study. Arch. Intern. Med. 164 (2004) 31-39
12. Chalkley S.N., Hettiarachchi M., Chisholm D.J., and Kraegen E.W. Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E1231-E1238
13. Bernardis L.L., and Patterson B.D. Correlation between 'Lee index' and carcass fat content in weanling and adult female rats with hypothalamic lesions. J. Endocrinol. 40 (1968) 527-528
14. Hamm J.K., Park B.H., and Farmer S.R. A role for C/EBPbeta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes. J. Biol. Chem. 276 (2001) 18464-18471
15. Liu J., Li H., Burstein S.H., Zurier R.B., and Chen J.D. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Mol. Pharmacol. 63 (2003) 983-992
16. Cheng L., Ding G., Qin Q., Xiao Y., Woods D., Chen Y.E., and Yang Q. Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. Biochem. Biophys. Res. Commun. 313 (2004) 277-286
17. Arrighi J.F., Pion M., Wiznerowicz M., Geijtenbeek T.B., Garcia E., Abraham S., Leuba F., Dutoit V., Ducrey-Rundquist O., van Kooyk Y., Trono D., and Piguet V. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J. Virol. 78 (2004) 10848-10855
18. Despres J.P., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., and Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10 (1990) 497-511
19. Bensaid M., Gary-Bobo M., Esclangon A., Maffrand J.P., Le Fur G., Oury-Donat F., and Soubrie P. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol. Pharmacol. 63 (2003) 908-914
20. Despres J.P., Golay A., and Sjostrom L. Rimonabant in obesity-lipids study group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 353 (2005) 2121-2134
21. Luquet S., Gaudel C., Holst D., Lopez-Soriano J., Jehl-Pietri C., Fredenrich A., and Grimaldi P.A. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. Biochim. Biophys. Acta 1740 (2005) 313-317
22. Gary-Bobo N., Elachouri G., Scatton B., LeFur G., Oury-Donat F., and Bensaid M. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Mol. Pharmacol. 69 (2006) 471-478